MucosaTec is among the final six candidates for this year’s Innovation Prize of the BioRegions in Germany, which aims to promote the economic utilization of modern biotechnologies. We will be presenting at the German Biotech Days on the 16th of April in Berlin and are incredibly excited to be part of this journey.
MucosaTec GmbH is presented in the Journal “Potenzial” (english: Potential) in the section “Talente” (english: Talents). The Journal is published by the Company WISTA owned by the city of Berlin. MucosaTec GmbH is presented in a comprehensive article covering the scientific basis, Prof. Lauster and his team, locations of the start-up in Berlin and the … Read more
MucosaTec GmbH was created as a spin-off of the MucBoost project. In the challenge „broad-spectrum antivirals“ by SPRIND – the Federal Agency for Disruptive Innovation – Germany, our project MucBoost was one of the winners of the third stage. The official Homepage presents pictures of some team members at work in our beautiful labs and … Read more
The Newspage of the 5th biggest national Newspaper in Germany – Welt – presents our research and the planned product in another big article (Welt+ required). The topic is wrapped different this time to fit in their “Health” section relating to the beginning of flu-season in Germany. Estimated 1.4 million readers are reached with the … Read more
November is flu-season in Germany. Therefore the 5th biggest national Newspaper in Germany – Welt – got the great idea to present our research and the planned product in a big article in their “Knowledge” section of the printed version. Estimated 1.4 million readers are reached with the printed paper and the web services of … Read more
Tagesspiegel.de highlights, in an article, our success in winning a challenge by the SPRIND agency of the Federal Ministry of Education and Research of Germany, and introduces the unique mechanism of action of our nasal spray currently in development. This nasal spray presents a novel approach in the creation of antiviral agents. With a significant … Read more
The COVID-19 pandemic has highlighted the urgent need for antiviral agents, generating significant interest in related research. Tagesspiegel.de hits this spot by discussing the MucBoost research project, involving multiple partners and focusing on our new antiviral mechanism of action in a thorough article. With its extensive reach of 9.2 million unique users per month, tagesspiegel.de … Read more
Learn more about the science behind our nasal spray in this video. The YouTube channel “Breaking Lab” presents the team MucBoost and other teams of the challenge “broad-spectrum antivirals”, which was launched by SPRIND, the Federal Agency for Disruptive Innovation – Germany. The MucBoost project is one of the winners of the challenge’s second stage
The local newspaper “Der Teckbote” has an affectionate report about a son of the city Kirchheim unter Teck – Dr. Daniel Lauster. The founding of his research group at the Freie University of Berlin and his “unappetizing” research topics are reported in detail. As unappetizing – with a wink – they mention the general research … Read more
© COPYRIGHT MUCOSATEC
